![Gilles A. Cottier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gilles A. Cottier
Geen lopende functies
Profiel
Gilles A. Cottier formerly worked at Actylis Corp., as Chief Executive Officer from 2019 to 2024, Aceto US LLC, as Chief Executive Officer, Research Essentials, as President from 2005 to 2009, Patheon NV, as President-Pharmaceutical Development Services from 2016 to 2017, Sigma-Aldrich Corp., as President-SAFC Commercial Business Unit from 2014 to 2015, and New Mountain Capital LLC, as Management Partner.
Mr. Cottier received his graduate degree from École Supérieure de Chimie Physique Électronique.
Eerdere bekende functies van Gilles A. Cottier
| Bedrijven | Functie | Einde |
|---|---|---|
| ACETO CORPORATION | Algemeen Directeur | 17-06-2024 |
| PATHEON N.V. | Corporate Officer/Principal | 29-08-2017 |
| SIGMA-ALDRICH CORPORATION | Corporate Officer/Principal | 01-12-2015 |
Research Essentials | President | 01-01-2009 |
Aceto US LLC
 Aceto US LLC Chemicals: Major DiversifiedProcess Industries Manufactures and supplies specialty chemicals | Algemeen Directeur | - |
Opleiding van Gilles A. Cottier
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
68
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Actylis Corp.
 Actylis Corp. Chemicals: Major DiversifiedProcess Industries Manufactures and supplies chemical compounds used in pharmaceutical, nutraceutical, agricultural and specialty chemical industries | Process Industries |
Sigma-Aldrich Corp.
 Sigma-Aldrich Corp. Pharmaceuticals: OtherHealth Technology Produces and develops pharmaceutical drug therapy products | Health Technology |
New Mountain Capital LLC
 New Mountain Capital LLC Investment ManagersFinance New Mountain Capital invests in middle market companies located in the United States with an enterprise value of USD 100 - 1000 million. The firm focuses on a broad range of sectors and industries. It provides financing for add-on acquisitions, buyout and growth transactions with a transaction size ranging USD 100 - 500 million. It also acquires majority control and minority equity positions. | Finance |
Research Essentials | |
École Supérieure de Chimie Physique Électronique
 École Supérieure de Chimie Physique Électronique Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Patheon NV
 Patheon NV Pharmaceuticals: MajorHealth Technology Provides pharmaceutical development and manufacturing services | Health Technology |
Aceto US LLC
Aceto US LLC Chemicals: Major DiversifiedProcess Industries Manufactures and supplies specialty chemicals | Process Industries |
Kies MarketScreener 
